Free Trial

Integer (NYSE:ITGR) Sets New 1-Year Low - Should You Sell?

Integer logo with Medical background

Key Points

  • Integer Holdings Corporation's stock reached a new 52-week low of $99.73 during trading, closing at $100.11 with significant volume of 654,541 shares.
  • Several analysts have revised their price targets, with Truist Financial decreasing theirs from $145 to $137 while Citigroup upgraded Integer to a "strong-buy" status with a price target increase to $140.
  • The company reported quarterly earnings showing a slight miss in EPS estimates, posting $1.55 versus an expected $1.57, but generated a revenue of $476 million, surpassing the consensus estimate of $464.37 million.
  • Five stocks we like better than Integer.

Integer Holdings Corporation (NYSE:ITGR - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $99.73 and last traded at $100.11, with a volume of 654541 shares traded. The stock had previously closed at $101.34.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ITGR shares. Truist Financial lowered their price target on Integer from $145.00 to $137.00 and set a "buy" rating for the company in a report on Friday, July 25th. Wall Street Zen upgraded Integer from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Raymond James Financial lowered their price target on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday, July 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and increased their price target for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Finally, Wells Fargo & Company lowered their price target on Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Integer presently has an average rating of "Buy" and an average price target of $140.25.

Get Our Latest Stock Analysis on ITGR

Integer Stock Performance

The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $3.51 billion, a P/E ratio of 44.10, a P/E/G ratio of 0.80 and a beta of 1.03. The stock has a fifty day moving average of $109.19 and a 200-day moving average of $115.67.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The firm had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.The firm's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, research analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ITGR. TD Private Client Wealth LLC boosted its holdings in Integer by 5.8% in the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock worth $180,000 after acquiring an additional 83 shares in the last quarter. CWM LLC raised its holdings in shares of Integer by 46.1% in the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider's stock worth $44,000 after acquiring an additional 112 shares during the last quarter. Xponance Inc. raised its holdings in shares of Integer by 5.1% in the 1st quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock worth $297,000 after acquiring an additional 122 shares during the last quarter. Bessemer Group Inc. raised its holdings in shares of Integer by 73.1% in the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after acquiring an additional 125 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Integer by 20.2% during the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider's stock valued at $98,000 after buying an additional 134 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

About Integer

(Get Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Integer Right Now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.